# Synapse 3D With Intravascular Indocyanine Green

> **NCT03953144** · PHASE1,PHASE2 · RECRUITING · sponsor: **St. Joseph's Healthcare Hamilton** · enrollment: 32 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer
- Primary Neoplasm

## Interventions

- **DEVICE:** Synapse 3D Lung Modelling
- **DRUG:** IC-Green (ICG)

## Key facts

- **NCT ID:** NCT03953144
- **Lead sponsor:** St. Joseph's Healthcare Hamilton
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-01
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03953144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03953144, "Synapse 3D With Intravascular Indocyanine Green". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT03953144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*